Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.25p
   
  • Change Today:
      0.001p
  • 52 Week High: 2.05
  • 52 Week Low: 1.10
  • Currency: UK Pounds
  • Shares Issued: 979.75m
  • Volume: 1,169,657
  • Market Cap: £12.29m
  • RiskGrade: 340

Regulatory News

Second Price Monitoring Extn 18-Nov-2022 11:05 RNS
Price Monitoring Extension 18-Nov-2022 11:00 RNS
Second Price Monitoring Extn 27-Oct-2022 16:40 RNS
Price Monitoring Extension 27-Oct-2022 16:35 RNS
Second Price Monitoring Extn 27-Oct-2022 14:05 RNS
Price Monitoring Extension 27-Oct-2022 14:00 RNS
Half-year Report 29-Sep-2022 08:00 RNS
Presentation at H.C. Wainwright Global Conference 01-Sep-2022 08:45 RNS
Appointment of Director of Quality 22-Aug-2022 07:00 RNS
Approval and Issuance of Antibody Patent 15-Aug-2022 07:00 RNS
Appointment of Medical Director 10-Aug-2022 07:00 RNS
Second Price Monitoring Extn 09-Aug-2022 14:06 RNS
Price Monitoring Extension 09-Aug-2022 14:00 RNS
New Custom R&D Facility Opening 13-Jul-2022 07:00 RNS
Investor Webinar Recording 08-Jul-2022 12:25 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.25p
Change Today 0.001p
% Change -0.08 %
52 Week High 2.05
52 Week Low 1.10
Volume 1,169,657
Shares Issued 979.75m
Market Cap £12.29m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.28% above the market average3.28% above the market average3.28% above the market average3.28% above the market average3.28% above the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Price Trend
62.43% below the market average62.43% below the market average62.43% below the market average62.43% below the market average62.43% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 01-Dec-2022

Time Volume / Share Price
12:52 32,553 @ 1.25p
11:43 976 @ 1.25p
11:33 13,738 @ 1.25p
11:02 23,823 @ 1.25p
10:33 5,000 @ 1.25p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page